213 related articles for article (PubMed ID: 9934342)
1. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.
Caro JJ; Speckman JL; Salas M; Raggio G; Jackson JD
CMAJ; 1999 Jan; 160(1):41-6. PubMed ID: 9934342
[TBL] [Abstract][Full Text] [Related]
2. Persistence with treatment for hypertension in actual practice.
Caro JJ; Salas M; Speckman JL; Raggio G; Jackson JD
CMAJ; 1999 Jan; 160(1):31-7. PubMed ID: 9934341
[TBL] [Abstract][Full Text] [Related]
3. Stepped care for hypertension: are the assumptions valid?
Caro JJ
J Hypertens Suppl; 1997 Dec; 15(7):S35-9. PubMed ID: 9532519
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
5. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
[TBL] [Abstract][Full Text] [Related]
6. Long-term persistence with antihypertensive drugs in new patients.
Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
[TBL] [Abstract][Full Text] [Related]
7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario.
Friedman O; McAlister FA; Yun L; Campbell NR; Tu K;
Am J Med; 2010 Feb; 123(2):173-81. PubMed ID: 20103027
[TBL] [Abstract][Full Text] [Related]
9. Existing treatment strategies: does noncompliance make a difference?
Caro JJ; Speckman JL
J Hypertens Suppl; 1998 Sep; 16(7):S31-4. PubMed ID: 9855029
[TBL] [Abstract][Full Text] [Related]
10. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.
Cardinal H; Monfared AA; Dorais M; LeLorier J
Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318
[TBL] [Abstract][Full Text] [Related]
11. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
[TBL] [Abstract][Full Text] [Related]
12. Choice of initial antihypertensive medication and continuation of use.
Grégoire JP
Can J Cardiol; 1999 Nov; 15 Suppl F():39F-41F. PubMed ID: 10579751
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
[TBL] [Abstract][Full Text] [Related]
14. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Grant RW; Singer DE; Meigs JB
Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
[TBL] [Abstract][Full Text] [Related]
15. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
16. Current recommendations for the treatment of hypertension: are they still valid?
Moser M
J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
[TBL] [Abstract][Full Text] [Related]
17. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
Taira DA; Wong KS; Frech-Tamas F; Chung RS
Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
[TBL] [Abstract][Full Text] [Related]
18. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
[TBL] [Abstract][Full Text] [Related]
19. The need for evidence in hypertension management: historical perspective.
Moawad MA
Ann Saudi Med; 2005; 25(5):367-74. PubMed ID: 16270757
[TBL] [Abstract][Full Text] [Related]
20. Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication.
Tamblyn R; Abrahamowicz M; Dauphinee D; Wenghofer E; Jacques A; Klass D; Smee S; Eguale T; Winslade N; Girard N; Bartman I; Buckeridge DL; Hanley JA
Arch Intern Med; 2010 Jun; 170(12):1064-72. PubMed ID: 20585073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
